We are live on
!
Find out more
GC
Gratry & Company Portfolio holdings
AUM
$72.2M
1-Year Est. Return
19.87%
This Fund
S&P 500
This Quarter
Est. Return
+7.24%
1 Year Est. Return
+19.87%
3 Year Est. Return
+44.17%
5 Year Est. Return
+89.51%
10 Year Est. Return
–
AUM
$128M
AUM Growth
+$1.12M
(+0.88%)
Cap. Flow
-$5.79M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
94
New
24
Increased
8
Reduced
41
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$3.65M |
| 2 |
Honda
HMC
|
+$3.51M |
| 3 |
ORIX
IX
|
+$3.37M |
| 4 |
Diageo
DEO
|
+$3.29M |
| 5 |
IFX
INFINEON TECH AG ADS(REP1 ORD)
IFX
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$4.49M |
| 2 |
Vodafone
VOD
|
+$3.71M |
| 3 |
Broadcom
AVGO
|
+$3.59M |
| 4 |
LyondellBasell Industries
LYB
|
+$3.27M |
| 5 |
BAY
BAYER AG SPONS ADR
BAY
|
+$2.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.4% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 9.46% |
| 4 | Materials | 8.24% |
| 5 | Consumer Discretionary | 7.24% |
Similar funds
T
DCM
XS
BSCP
SCM
FMA
MSTVIM
LA
Gratry & Company's Q3 2016 Portfolio in Review
As of Q3 2016, Gratry & Company held 94 positions worth $128M, up 0.88% from $127M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Gratry & Company withdrew a net $5.79M in Q3 2016, closing 15 positions and reducing 41 holdings. Its most notable exit was Novo Nordisk, an estimated $4.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Gratry & Company opened a new position in Rio Tinto worth $3.83M.
- Gratry & Company's largest Q3 2016 buy was Rio Tinto: 114,667 shares worth $3.83M.
- Gratry & Company added most to Cemex in Q3 2016, an estimated $1.6M increase.
- Gratry & Company's biggest Q3 2016 reduction was Broadcom, cutting an estimated $3.59M.
- Gratry & Company fully exited Novo Nordisk in Q3 2016, selling an estimated $4.49M.
- Gratry & Company's ten largest holdings make up 35% of its $128M portfolio in Q3 2016.
- Gratry & Company opened 24 new positions and closed 15 in Q3 2016.
- Gratry & Company's portfolio value rose 0.88% quarter-over-quarter to $128M.
Based on Gratry & Company's 13F filing for Q3 2016, filed 4 Nov 2016.